← Back to headlines
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference
6 Mar, 02:07 — 6 Mar, 02:07
Sources
Showing 1 of 1 sources
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
3h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
5h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
10h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
10h ago